BioGenex Laboratories Overview
Pro stress-test →BioGenex designs, develops, and commercializes automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The company operates with a global reach of 70+ distributors across 47 countries and serves pathologists, histotechnologists, reference labs, clinical lab professionals, pharmaceutical/biotechnology and academic researchers.
Strategic Profile
Pro stress-test →BioGenex's industry-leading next-generation cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are revolutionizing pathology. The company prides itself on delivering innovative products, years ahead of the competition in the field of immunohistochemistry (IHC) and in situ hybridization (ISH).
Competitive Landscape
Pro stress-test →Competitors include Randox, Response Genetics, T2 Biosystems, Myriad Genetics, and Sysmex Nederland in the diagnostic equipment and molecular pathology space. BioGenex differentiates through proprietary automation technology and comprehensive product portfolio serving precision cancer diagnostics.
Industry Context
BioGenex Laboratories operates in Molecular pathology diagnostic systems.
Key facts
Founded: 1981 · Headquarters: Fremont, US · Employees: 250